3,000
Participants
Start Date
June 17, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Isoniazid and Rifapentine (INH-RPT)
Oral combination of rifapentine (RPT, 900 mg) and isoniazid (INH, 900 mg), once-weekly for 12 weeks.
Placebo
Participants in the control group will receive placebo once weekly for 12 weeks
RECRUITING
Mbeya zonal referral hospital, Mbeya
RECRUITING
Kilimanjaro Christian Medical Center, Moshi
RECRUITING
Makerere University, Kampala
RECRUITING
Martyrs Hospital Lubaga, Kampala
Stichting Katholieke Universiteit- Radboudumc (RUMC), Netherlands
UNKNOWN
Otago University, New Zealand
UNKNOWN
Makerere University
OTHER
St George's, University of London, United Kingdom
UNKNOWN
Kilimanjaro Christian Medical University College (KCMUCo), Tanzania
UNKNOWN
Uganda Martyrs Hospital Lubaga, Uganda
UNKNOWN
King's College London
OTHER
Dr. Nyanda Elias Ntinginya
OTHER_GOV